DOI
https://doi.org/10.25772/ZBRA-DW79
Defense Date
2008
Document Type
Thesis
Degree Name
Master of Science
Department
Medicinal Chemistry
First Advisor
Yan Zhang
Abstract
There are currently many opioid agonists available for clinical use as analgesics. However, many of these opioid agonists have notorious side effects including respiratory depression and may lead to addiction and dependence. Problems associated with these opioid agonists are determined to come from their interactions with the mu-opioid receptor. Opioid antagonists, such as naltrexone, have shown to aid in the treatment of opioid addiction. Although naltrexone has high affinity to the mu-opioid receptor, it lacks selectivity. Novel selective mu-opioid receptor antagonists were designed based on the identification of important pharmacophore elements in several known mu-opioid receptor agonists and antagonists. These compounds were synthesized and in vitro biological assays were conducted to determine their affinity to all three opioid receptors. Also, molecular modeling studines were conducted to help visualize the interactions between the mu-opioid receptor and these ligands. Finally, four lead compounds have been identified for further optimization.
Rights
© The Author
Is Part Of
VCU University Archives
Is Part Of
VCU Theses and Dissertations
Date of Submission
November 2008